Skip to main content
Akso Health Group logo

Akso Health Group — Investor Relations & Filings

Ticker · AHG ISIN · US98422P1084 LEI · 5493007BHBTZESVSIA24 US Human health and social work activities
Open in API
Filings indexed 190 across all filing types
Latest filing 2019-07-31 Annual Report
Country KY Cayman Islands
Listing US AHG

About Akso Health Group

https://www.ahgtop.com/en/index.html

Akso Health Group operates a social e-commerce platform that collaborates with other domestic e-commerce platforms to offer users a wide selection of products. The company is also developing a new business as a cancer therapy and radiotherapy oncology service provider. This expansion includes plans to open vaccine research centers and radiation oncology centers. These facilities will offer specialized radiation therapy, personalized consultation, conventional treatment planning, and other cancer-related treatment services for patients in need of varying stages of care.

Recent filings

Filing Released Lang Actions
20-F
Annual Report FY 2019
2019-07-31 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Hexindai Inc., pursuant to SEC rules under the Securities Exchange Act of 1934. Form 6-K is typically used for submitting current reports and other information by foreign private issuers. The document length is short (1810 characters) and includes a press release as an exhibit. There is no substantive financial data or detailed report content present, only a brief filing and an exhibit index. According to the rules, such a short document that primarily serves as a report submission or announcement without detailed financial statements or analysis should be classified as a Regulatory Filing (RNS).
2019-07-01 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Hexindai Inc., pursuant to SEC rules under the Securities Exchange Act of 1934. Form 6-K is used by foreign private issuers to report material information that is not required to be filed on Form 20-F (annual report). The document is short (1814 characters) and includes a signature and an exhibit index referencing a press release. There is no substantive financial data or detailed report content present. According to the rules, such a filing is a regulatory announcement or miscellaneous filing that does not fit into other specific categories. Therefore, it should be classified as Regulatory Filings (RNS).
2019-06-18 English
Regulatory Filings 2019
Regulatory Filings Classification · 50% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. Without any discernible information or context, it is impossible to classify this document as any specific filing type. Given the lack of meaningful content, the appropriate classification is the fallback category, Regulatory Filings (RNS). The confidence is moderate due to the inability to analyze the content meaningfully.
2019-06-13 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, Hexindai Inc., for June 2019. Form 6-K is used by foreign private issuers to report material information that is not required to be filed on Form 20-F. The document is short (1808 characters) and includes a press release as an exhibit. There is no substantive financial data or detailed report content, only a notification/report filing with an exhibit index. According to the rules, such filings that are announcements or reports of information but do not contain full financial statements or detailed analysis should be classified as Regulatory Filings (RNS).
2019-06-13 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter from the company's legal counsel responding to comments from the SEC staff regarding the company's Annual Report on Form 20-F for the fiscal year ended March 31, 2018. It discusses specific disclosures and internal controls related to credit background investigations and revenue decline, referencing the prior filed 20-F and the upcoming 2019 Annual Report. The document is correspondence addressing SEC comments rather than the Annual Report itself. It contains no financial statements or substantive financial data but is a regulatory response letter. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory correspondence and not the report itself.
2019-06-04 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.